Spero Therapeutics, Inc. (SPRO)
NASDAQ·Healthcare·Biotechnology
$2.69
+0.56%
Mkt Cap $130.71M
No analyst coverage available
We don't have analyst ratings or price target data for Spero Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.